|

Pelabresib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CPI-0610

Pipeline

Phase 3: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • Advanced Malignancies1
  • Hematologic Malignancy1
  • Solid Tumor1
  • Cancer1

Los Angeles, California1 trial

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Hematologic Malignancy/Stem (Department of Medicine, Division of Hematology/Oncology)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.